RAZADYNE®

NCT00236574 – A Randomized Double Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer’s Disease

Posted on June 8, 2016 by tsuperadmin -

NCT00253214 – Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer’s Disease: Safety and Efficacy of a Controlled-Release Formulation

Posted on June 8, 2016 by tsuperadmin -

NCT00253188 – Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer’s Disease

Posted on June 8, 2016 by tsuperadmin -

NCT00261573 – The Safety and Efficacy of Galantamine in the Treatment of Vascular and Mixed Dementia

Posted on June 8, 2016 by tsuperadmin -

Long Term Safety and Efficacy of Galantamine in the treatment of Alzheimer’s Disease

Posted on February 11, 2015 by tsuperadmin -

Long Term Safety and Efficacy of Galantamine in the treatment of Alzheimer’s Disease

Posted on February 11, 2015 by tsuperadmin -

NCT00216502 – Long Term Treatment With Galantamine In Dementia

Posted on February 10, 2015 by tsuperadmin -

NCT00253227 – Galantamine in the Treatment of Alzheimer’s Disease: Flexible Dose Range Trial

Posted on January 30, 2015 by tsuperadmin -

NCT00304629 – Long Term Safety and Efficacy of Galantamine in Alzheimer’s Disease (Extension INT-8)

Posted on January 30, 2015 by tsuperadmin -

NCT00253201 – Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer’s Disease

Posted on January 30, 2015 by tsuperadmin -